Résumé
Sulfites are among the 37 excipients with a possible known effect listed by the French Health Autorities (ANSM) that can be found in French pharmaceutical registered drug. They are likely to cause severe hypersensitivity reactions and bronchospasm in intolerant patients. Guidelines on how to deal with sulfite hypersensitivity are limited to “avoidance of wines and products containing large amounts of sulfites”, without specifying the risk – if any – of prescribing and dispensing sulfite-containing medications.
Titre traduit de la contribution | Sulfite derivatives use in french pharmaceutical products in 2022 |
---|---|
langue originale | Français |
Pages (de - à) | 109-118 |
Nombre de pages | 10 |
journal | Journal de Pharmacie Clinique |
Volume | 42 |
Numéro de publication | 3 |
Les DOIs | |
état | Publié - 1 sept. 2023 |
mots-clés
- excipient intolerance
- sulfite intolerance
- sulfites